Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$23.7K Sell
722
-2
-0.3% -$73 0.01% 357
2022
Q1
$26.3K Sell
724
-39
-5% -$1.44K 0.01% 640
2021
Q4
$28.7K Buy
763
+71
+10% +$2.32K 0.01% 552
2021
Q3
$18.9K Sell
692
-3,021
-81% -$86.8K ﹤0.01% 682
2021
Q2
$105K Sell
3,713
-11,891
-76% -$380K 0.02% 530
2021
Q1
$495K Sell
15,604
-7,434
-32% -$205K 0.14% 146
2020
Q4
$567K Sell
23,038
-30,453
-57% -$639K 0.17% 130
2020
Q3
$1.02M Sell
53,491
-70,785
-57% -$1.29M 0.29% 79
2020
Q2
$2.17M Buy
124,276
+122,061
+5,511% +$1.94M 0.58% 45
2020
Q1
$38.5K Hold
2,215
0.01% 375
2019
Q4
$47.4K Sell
2,215
-179,244
-99% -$3.4M 0.01% 358
2019
Q3
$3.43M Buy
181,459
+7,101
+4% +$139K 0.62% 39
2019
Q2
$3.62M Sell
174,358
-20,166
-10% -$399K 0.64% 42
2019
Q1
$3.78M Buy
194,524
+42,102
+28% +$892K 0.75% 39
2018
Q4
$3.12M Buy
152,422
+25,459
+20% +$594K 0.56% 53
2018
Q3
$3.27M Buy
126,963
+28,227
+29% +$682K 0.61% 38
2018
Q2
$2.24M Buy
98,736
+1,497
+2% +$33.4K 0.37% 63
2018
Q1
$2.11M Buy
97,239
+60,847
+167% +$1.37M 0.42% 63
2017
Q4
$764K Buy
36,392
+31,465
+639% +$669K 0.13% 132
2017
Q3
$98.3K Sell
4,927
-2,873
-37% -$54.7K 0.02% 263
2017
Q2
$136K Buy
7,800
+4,474
+135% +$82.1K 0.03% 238
2017
Q1
$59.5K Sell
3,326
-4,840
-59% -$78.3K 0.01% 256
2016
Q4
$121K Sell
8,166
-1,067
-12% -$16.2K 0.02% 234
2016
Q3
$143K Sell
9,233
-136
-1% -$1.94K 0.02% 219
2016
Q2
$118K Buy
9,369
+1,831
+24% +$22.8K 0.02% 232
2016
Q1
$92.9K Sell
7,538
-880
-10% -$9.41K 0.01% 250
2015
Q4
$99.7K Sell
8,418
-18,143
-68% -$232K 0.01% 205
2015
Q3
$309K Buy
26,561
+8,665
+48% +$113K 0.04% 157
2015
Q2
$244K Sell
17,896
-350
-2% -$5.2K 0.03% 193
2015
Q1
$258K Buy
18,246
+10,647
+140% +$176K 0.03% 189
2014
Q4
$138K Buy
+7,599
New +$127K 0.02% 254

Other funds holding HPQ

Exane Derivatives's HPQ Position: Q2 2022 in Review

Exane Derivatives reduced its HP (HPQ) stake by 0.28% in Q2 2022, selling an estimated $73 and leaving 722 shares worth $23.7K. The position accounts for 0.01% of the portfolio, ranked #357.

Exane Derivatives first reported a position in HPQ in Q4 2014 and has held it in 31 quarters since. The position peaked at $3.78M in Q1 2019. 1,091 funds tracked by Wall St. Rank hold HPQ as of Q2 2022.

  • Exane Derivatives held 722 shares of HP worth $23.7K as of Q2 2022.
  • Exane Derivatives sold 2 HP shares in Q2 2022, an estimated $73.
  • HP made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #357 holding.
  • Exane Derivatives first reported a position in HP in Q4 2014 and has held it in 31 quarters since.
  • Exane Derivatives's HP position peaked at $3.78M in Q1 2019.
  • 1,091 funds tracked by Wall St. Rank held HP as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.